These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9188586)

  • 21. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
    Bramson JL; Hitt M; Gauldie J; Graham FL
    Gene Ther; 1997 Oct; 4(10):1069-76. PubMed ID: 9415313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Readministration of helper-dependent adenovirus to mouse lung.
    Koehler DR; Martin B; Corey M; Palmer D; Ng P; Tanswell AK; Hu J
    Gene Ther; 2006 May; 13(9):773-80. PubMed ID: 16437131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.
    Schowalter DB; Himeda CL; Winther BL; Wilson CB; Kay MA
    J Virol; 1999 Jun; 73(6):4755-66. PubMed ID: 10233936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression.
    Michou AI; Santoro L; Christ M; Julliard V; Pavirani A; Mehtali M
    Gene Ther; 1997 May; 4(5):473-82. PubMed ID: 9274725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector.
    Lena AM; Giannetti P; Sporeno E; Ciliberto G; Savino R
    J Gene Med; 2005 Aug; 7(8):1086-96. PubMed ID: 15772935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors.
    Pastore L; Morral N; Zhou H; Garcia R; Parks RJ; Kochanek S; Graham FL; Lee B; Beaudet AL
    Hum Gene Ther; 1999 Jul; 10(11):1773-81. PubMed ID: 10446917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors.
    Liu Q; Zaiss AK; Colarusso P; Patel K; Haljan G; Wickham TJ; Muruve DA
    Hum Gene Ther; 2003 May; 14(7):627-43. PubMed ID: 12804145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression.
    DeMatteo RP; Chu G; Ahn M; Chang E; Barker CF; Markmann JF
    J Virol; 1997 Jul; 71(7):5330-5. PubMed ID: 9188602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.
    Mercier S; Gahéry-Segard H; Monteil M; Lengagne R; Guillet JG; Eloit M; Denesvre C
    J Virol; 2002 Mar; 76(6):2899-911. PubMed ID: 11861857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
    Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
    J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-administration of adenovirus vector expressing CTLA4-Ig prolongs transgene expression in the brain of mice sensitized with adenovirus.
    Uchida T; Kajiwara K; Ideguchi M; Yoshikawa K; Morioka J; Suzuki M
    Brain Res; 2001 Apr; 898(2):272-80. PubMed ID: 11306013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
    Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
    Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus.
    Krebs P; Scandella E; Odermatt B; Ludewig B
    J Immunol; 2005 Apr; 174(8):4559-66. PubMed ID: 15814677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung.
    Minter RM; Rectenwald JE; Fukuzuka K; Tannahill CL; La Face D; Tsai V; Ahmed I; Hutchins E; Moyer R; Copeland EM; Moldawer LL
    J Immunol; 2000 Jan; 164(1):443-51. PubMed ID: 10605041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.
    Diao J; Smythe JA; Smyth C; Rowe PB; Alexander IE
    Gene Ther; 1999 May; 6(5):845-53. PubMed ID: 10505110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
    Kuzmin AI; Galenko O; Eisensmith RC
    Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice.
    Fields PA; Armstrong E; Hagstrom JN; Arruda VR; Murphy ML; Farrell JP; High KA; Herzog RW
    Gene Ther; 2001 Mar; 8(5):354-61. PubMed ID: 11313811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.